Notably, no significant difference was observed between CD19/NKG2DL tandem and NKG2DL single CAR T-cell in this model, suggesting that the expression of NKG2DL on the Nalm-6 cells was sufficient to reduce tumor burden significantly. Here, CD19 is linked to neoplasm.